Structure and functional analysis of the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein

PLoS Pathogens

Volumn 8, Issue 5, 2012, Pages

  Blondot, Marie Lise ^a   Dubosclard, Virginie ^a   Fix, Jenna ^a   Lassoued, Safa ^b   Aumont Nicaise, Magali ^c   Bontems, François ^b   Eléouët, Jean François ^a   Sizun, Christina ^b  

^a INRA Institut National de la Recherche Agronomique   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOPROTEIN; PROTEIN M2 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; P PROTEIN, HUMAN RESPIRATORY SYNCYTIAL VIRUS; RECOMBINANT PROTEIN; RNA BINDING PROTEIN; VIRUS RNA;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CYTOPLASM; EBOLA VIRUS; GENOME; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA BINDING; RNA SYNTHESIS; SITE DIRECTED MUTAGENESIS; VIRUS NUCLEOCAPSID; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; POINT MUTATION; PROTEIN DOMAIN; PROTEIN TERTIARY STRUCTURE; VIRUS INCLUSION;

EBOLA VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

INCLUSION BODIES, VIRAL; MUTAGENESIS, SITE-DIRECTED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; POINT MUTATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RNA, VIRAL; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; VIRAL STRUCTURAL PROTEINS;

EID: 84863658768     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002734     Document Type: Article

References (60)

1. Collins PL, Crowe JE, (2007) Respiratory Syncytial Virus and Metapneumovirus. In: Knipe DM, Howley PM, editors. Fields Virology, 5th ed Philadelphia Lippincott Williams & Wilkins pp. 1601-1646.
2. Meyer G, Deplanche M, Schelcher F, (2008) Human and bovine respiratory syncytial virus vaccine research and development. Comp Immunol Microbiol Infect Dis 31: 191-225.
3. Cowton VM, McGivern DR, Fearns R, (2006) Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol 87: 1805-1821.
4. Sutherland KA, Collins PL, Peeples ME, (2001) Synergistic effects of gene-end signal mutations and the M2-1 protein on transcription termination by respiratory syncytial virus. Virology 288: 295-307.
5. Kuo L, Grosfeld H, Cristina J, Hill MG, Collins PL, (1996) Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus. J Virol 70: 6892-6901.
6. Fearns R, Collins PL, (1999) Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol 73: 5852-5864.
7. Collins PL, Hill MG, Cristina J, Grosfeld H, (1996) Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci U S A 93: 81-85.
8. Hardy RW, Wertz GW, (1998) The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J Virol 72: 520-526.
9. Hardy RW, Harmon SB, Wertz GW, (1999) Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination. J Virol 73: 170-176.
10. Cartee TL, Wertz GW, (2001) Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection. J Virol 75: 12188-12197.
11. Garcia J, Garcia-Barreno B, Vivo A, Melero JA, (1993) Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. Virology 195: 243-247.
12. Heinrich BS, Cureton DK, Rahmeh AA, Whelan SP, (2010) Protein expression redirects vesicular stomatitis virus RNA synthesis to cytoplasmic inclusions. PLoS Pathog 6: e1000958.
13. Cuesta I, Geng X, Asenjo A, Villanueva N, (2000) Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein. J Virol 74: 9858-9867.
14. Mason SW, Aberg E, Lawetz C, DeLong R, Whitehead P, et al. (2003) Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity. J Virol 77: 10670-10676.
15. Tran TL, Castagne N, Dubosclard V, Noinville S, Koch E, et al. (2009) The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol 83: 6363-6374.
16. Esperante SA, Chemes LB, Sanchez IE, Prat-Gay GD, (2011) The respiratory syncytial virus transcription antiterminator M2-1 is highly stable, zinc binding tetramer with a strong pH dependent dissociation and a monomeric unfolding intermediate. Biochemistry 50: 8529-8529.
17. Hardy RW, Wertz GW, (2000) The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function. J Virol 74: 5880-5885.
18. Tang RS, Nguyen N, Cheng X, Jin H, (2001) Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability. J Virol 75: 11328-11335.
19. Zhou H, Cheng X, Jin H, (2003) Identification of amino acids that are critical to the processivity function of respiratory syncytial virus M2-1 protein. J Virol 77: 5046-5053.
20. Dubosclard V, Blondot ML, Eleouet JF, Bontems F, Sizun C, (2011) 1H, 13C, and 15N resonance assignment of the central domain of hRSV transcription antitermination factor M2-1. Biomol NMR Assign 5: 237-239.
21. Dickens LE, Collins PL, Wertz GW, (1984) Transcriptional mapping of human respiratory syncytial virus. J Virol 52: 364-369.
22. Zuker M, (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415.
23. Nakanishi T, Miyazawa M, Sakakura M, Terasawa H, Takahashi H, et al. (2002) Determination of the interface of a large protein complex by transferred cross-saturation measurements. J Mol Biol 318: 245-249.
24. Asenjo A, Calvo E, Villanueva N, (2006) Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex. J Gen Virol 87: 3637-3642.
25. Castagne N, Barbier A, Bernard J, Rezaei H, Huet JC, et al. (2004) Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain. J Gen Virol 85: 1643-1653.
26. Llorente MT, Garcia-Barreno B, Calero M, Camafeita E, Lopez JA, et al. (2006) Structural analysis of the human respiratory syncytial virus phosphoprotein: characterization of an alpha-helical domain involved in oligomerization. J Gen Virol 87: 159-169.
27. Collins PL, Mink MA, Hill MG 3rd, Camargo E, Grosfeld H, et al. (1993) Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA. Virology 195: 252-256.
28. Kuo L, Fearns R, Collins PL, (1996) The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J Virol 70: 6143-6150.
29. Weik M, Modrof J, Klenk HD, Becker S, Muhlberger E, (2002) Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol 76: 8532-8539.
30. Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S, (1999) Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J Virol 73: 2333-2342.
31. Grosfeld H, Hill MG, Collins PL, (1995) RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol 69: 5677-5686.
32. Yu Q, Hardy RW, Wertz GW, (1995) Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J Virol 69: 2412-2419.
33. Collins PL, Hill MG, Camargo E, Grosfeld H, Chanock RM, et al. (1995) Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci U S A 92: 11563-11567.
34. Volchkov VE, Volchkova VA, Muhlberger E, Kolesnikova LV, Weik M, et al. (2001) Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 291: 1965-1969.
35. Enterlein S, Volchkov V, Weik M, Kolesnikova L, Volchkova V, et al. (2006) Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol 80: 1038-1043.
36. John SP, Wang T, Steffen S, Longhi S, Schmaljohn CS, et al. (2007) Ebola virus VP30 is an RNA binding protein. J Virol 81: 8967-8976.
37. Modrof J, Becker S, Muhlberger E, (2003) Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol 77: 3334-3338.
38. Hartlieb B, Muziol T, Weissenhorn W, Becker S, (2007) Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad Sci U S A 104: 624-629.
39. Holm L, Rosenstrom P, (2010) Dali server: conservation mapping in 3D. Nucleic Acids Res 38: W545-549.
40. Becker S, Rinne C, Hofsass U, Klenk HD, Muhlberger E, (1998) Interactions of Marburg virus nucleocapsid proteins. Virology 249: 406-417.
41. Hartlieb B, Modrof J, Muhlberger E, Klenk HD, Becker S, (2003) Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem 278: 41830-41836.
42. Rahmeh AA, Schenk AD, Danek EI, Kranzusch PJ, Liang B, et al. (2010) Molecular architecture of the vesicular stomatitis virus RNA polymerase. Proc Natl Acad Sci U S A 107: 20075-20080.
43. Green TJ, Luo M, (2009) Structure of the vesicular stomatitis virus nucleocapsid in complex with the nucleocapsid-binding domain of the small polymerase cofactor, P. Proc Natl Acad Sci U S A 106: 11713-11718.
44. Llorente MT, Taylor IA, Lopez-Vinas E, Gomez-Puertas P, Calder LJ, et al. (2008) Structural properties of the human respiratory syncytial virus P protein: evidence for an elongated homotetrameric molecule that is the smallest orthologue within the family of paramyxovirus polymerase cofactors. Proteins 72: 946-958.
45. Kingston RL, Hamel DJ, Gay LS, Dahlquist FW, Matthews BW, (2004) Structural basis for the attachment of a paramyxoviral polymerase to its template. Proc Natl Acad Sci U S A 101: 8301-8306.
46. Groseth A, Charton JE, Sauerborn M, Feldmann F, Jones SM, et al. (2009) The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res 140: 8-14.
47. Buchholz UJ, Finke S, Conzelmann KK, (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251-259.
48. Fix J, Galloux M, Blondot ML, Eleouet JF, (2011) The insertion of fluorescent proteins in a variable region of respiratory syncytial virus L polymerase results in fluorescent and functional enzymes but with reduced activities. Open Virol J 5: 103-108.
49. Jin H, Clarke D, Zhou HZ, Cheng X, Coelingh K, et al. (1998) Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV. Virology 251: 206-214.
50. Garcia-Barreno B, Steel J, Paya M, Martinez-Sobrido L, Delgado T, et al. (2005) Epitope mapping of human respiratory syncytial virus 22K transcription antitermination factor: role of N-terminal sequences in protein folding. J Gen Virol 86: 1103-1107.
51. Snoussi K, Nonin-Lecomte S, Leroy JL, (2001) The RNA i-motif. J Mol Biol 309: 139-153.
52. Dubosclard V, Blondot ML, Eleouet JF, Bontems F, Sizun C, (2011) 1H, 13C, and 15N resonance assignment of the central domain of hRSV transcription antitermination factor M2-1. Biomol NMR Assign 5: 237-9.
53. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6: 277-293.
54. Goddard TD, Kneller DG, (2008) SPARKY, version 3. Available:http://www.cgl.ucsf.edu/home/sparky/.
55. Herrmann T, Guntert P, Wuthrich K, (2002) Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319: 209-227.
56. Schwieters CD, Kuszewski JJ, Clore GM, (2006) Using Xplor-NIH for NMR molecular structure determination. Prog NMR Spectrosc 48: 47-62.
57. Schrodinger L, (2010) The PyMOL Molecular Graphics System, version 1.3. Available:http://www.pymol.org.
58. Rocchia W, Alexov E, Honig B, (2001) Extending the applicability of the nonlinear Poisson-Boltzmann equation: Multiple dielectric constants and multivalent ions. J Phys Chem B 105: 6507-6514.
59. Sitkoff D, Sharp KA, Honig B, (1994) Accurate calculation of hydration free energies using macroscopic solvent models. J Phys Chem 98: 1978-1988.
60. Gouet P, Courcelle E, Stuart DI, Metoz F, (1999) ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 15: 305-308.